{"id":"https://openalex.org/W7204233327","doi":"https://doi.org/10.53295/cmb.v1.i1.100005","title":"Identification of Potent Inhibitors of Ephrin type-A receptor 1 using Virtual Screening and Molecular Dynamics Simulation Approach","display_name":"Identification of Potent Inhibitors of Ephrin type-A receptor 1 using Virtual Screening and Molecular Dynamics Simulation Approach","publication_year":2026,"publication_date":"2026-06-30","ids":{"openalex":"https://openalex.org/W7204233327","doi":"https://doi.org/10.53295/cmb.v1.i1.100005"},"language":"en","primary_location":{"id":"doi:10.53295/cmb.v1.i1.100005","doi":"https://doi.org/10.53295/cmb.v1.i1.100005","is_oa":true,"landing_page_url":"https://doi.org/10.53295/cmb.v1.i1.100005","pdf_url":"https://www.editorypress.uz/cmb/vol-1-no-1/100005/100005.pdf","source":{"id":"https://openalex.org/S7407064023","display_name":"Clinical & Molecular Biomedicine","issn_l":"3093-947X","issn":["3093-947X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical & Molecular Biomedicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.editorypress.uz/cmb/vol-1-no-1/100005/100005.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040929870","display_name":"Shanza Rehman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59475050","display_name":"Jamia Millia Islamia","ror":"https://ror.org/00pnhhv55","country_code":"IN","type":"education","lineage":["https://openalex.org/I59475050"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shanza Rehman","raw_affiliation_strings":["Department of Computer Science, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Computer Science, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India","institution_ids":["https://openalex.org/I59475050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008896830","display_name":"Sana Kauser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59475050","display_name":"Jamia Millia Islamia","ror":"https://ror.org/00pnhhv55","country_code":"IN","type":"education","lineage":["https://openalex.org/I59475050"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sana Kauser","raw_affiliation_strings":["Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India","institution_ids":["https://openalex.org/I59475050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047091665","display_name":"Syed Suhail Andrabi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syed Suhail Andrabi","raw_affiliation_strings":["Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084485764","display_name":"Nida Mubin","orcid":"https://orcid.org/0000-0001-9399-5008","observed_orcids":["https://orcid.org/0000-0001-9399-5008"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nida Mubin","raw_affiliation_strings":["Division of Haematology & Oncology, Case Western Reserve University, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Haematology & Oncology, Case Western Reserve University, Cleveland, OH, USA","institution_ids":["https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5493748,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"1","issue":"1","first_page":"30","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epha1","display_name":"EphA1","score":0.9629999995231628},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/natural-product-inhibitors","display_name":"natural product inhibitors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cancer-therapeutics","display_name":"cancer therapeutics","score":0.5640000104904175},{"id":"https://openalex.org/keywords/lead-identification","display_name":"lead compound identification","score":0.515999972820282},{"id":"https://openalex.org/keywords/drug-likeness-prediction","display_name":"drug-likeness prediction","score":0.5879999995231628},{"id":"https://openalex.org/keywords/carcinogenicity-assessment","display_name":"carcinogenicity assessment","score":0.6629999876022339},{"id":"https://openalex.org/keywords/protein-ligand-binding-stability","display_name":"protein-ligand binding stability","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.8159999847412109},{"id":"https://openalex.org/C59593255","wikidata":"https://www.wikidata.org/wiki/Q901663","display_name":"Molecular dynamics","level":2,"score":0.7332000136375427},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7006999850273132},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.642300009727478},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.5041000247001648},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.45879998803138733},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.41179999709129333},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.3928000032901764},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.38940000534057617},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.38670000433921814},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.38370001316070557},{"id":"https://openalex.org/C41847442","wikidata":"https://www.wikidata.org/wiki/Q916723","display_name":"Lipinski's rule of five","level":4,"score":0.37560001015663147},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.37070000171661377},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3677999973297119},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3637999892234802},{"id":"https://openalex.org/C168568712","wikidata":"https://www.wikidata.org/wiki/Q909999","display_name":"Radius of gyration","level":3,"score":0.352400004863739},{"id":"https://openalex.org/C3020299119","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Binding pocket","level":3,"score":0.34459999203681946},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.3418000042438507},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.32910001277923584},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.3287000060081482},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.3278000056743622},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.3043000102043152},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.29170000553131104},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.29019999504089355},{"id":"https://openalex.org/C169627665","wikidata":"https://www.wikidata.org/wiki/Q5767913","display_name":"Homology modeling","level":3,"score":0.28450000286102295},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.2793000042438507},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.27630001306533813},{"id":"https://openalex.org/C179303850","wikidata":"https://www.wikidata.org/wiki/Q4300362","display_name":"Molecular recognition","level":3,"score":0.26980000734329224},{"id":"https://openalex.org/C47701112","wikidata":"https://www.wikidata.org/wiki/Q735188","display_name":"Protein structure","level":2,"score":0.2671999931335449},{"id":"https://openalex.org/C2777735830","wikidata":"https://www.wikidata.org/wiki/Q6507061","display_name":"Molecular binding","level":3,"score":0.25529998540878296},{"id":"https://openalex.org/C2780430158","wikidata":"https://www.wikidata.org/wiki/Q7685902","display_name":"Target protein","level":3,"score":0.2531000077724457},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.2529999911785126}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.53295/cmb.v1.i1.100005","doi":"https://doi.org/10.53295/cmb.v1.i1.100005","is_oa":true,"landing_page_url":"https://doi.org/10.53295/cmb.v1.i1.100005","pdf_url":"https://www.editorypress.uz/cmb/vol-1-no-1/100005/100005.pdf","source":{"id":"https://openalex.org/S7407064023","display_name":"Clinical & Molecular Biomedicine","issn_l":"3093-947X","issn":["3093-947X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical & Molecular Biomedicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.53295/cmb.v1.i1.100005","doi":"https://doi.org/10.53295/cmb.v1.i1.100005","is_oa":true,"landing_page_url":"https://doi.org/10.53295/cmb.v1.i1.100005","pdf_url":"https://www.editorypress.uz/cmb/vol-1-no-1/100005/100005.pdf","source":{"id":"https://openalex.org/S7407064023","display_name":"Clinical & Molecular Biomedicine","issn_l":"3093-947X","issn":["3093-947X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical & Molecular Biomedicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204233327.pdf","grobid_xml":"https://content.openalex.org/works/W7204233327.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1862417723","https://openalex.org/W1984339376","https://openalex.org/W2009867031","https://openalex.org/W2021362806","https://openalex.org/W2043509228","https://openalex.org/W2083227014","https://openalex.org/W2176516200","https://openalex.org/W2910512414","https://openalex.org/W3013052957","https://openalex.org/W3087642359","https://openalex.org/W3093723328","https://openalex.org/W3094640617","https://openalex.org/W3168530307","https://openalex.org/W3208999135"],"related_works":["https://openalex.org/W4402494774","https://openalex.org/W2055386156","https://openalex.org/W2146190559","https://openalex.org/W4394411106","https://openalex.org/W4311548190","https://openalex.org/W4362596113","https://openalex.org/W2937418703","https://openalex.org/W4391027762","https://openalex.org/W4413456426","https://openalex.org/W4381335776"],"abstract_inverted_index":{"Ephrin":[0],"type-A":[1],"receptor":[2,7],"1":[3],"(EphA1)":[4],"is":[5],"a":[6,31,206],"tyrosine":[8],"kinase":[9,147],"implicated":[10],"in":[11,25],"tumor":[12],"progression,":[13],"angiogenesis,":[14],"metastasis,":[15],"and":[16,81,103,115,121,130,157,186,199],"immune":[17],"regulation,":[18],"making":[19],"it":[20],"an":[21],"attractive":[22],"therapeutic":[23],"target":[24],"cancer.":[26],"In":[27],"the":[28,53,78,97,142,146,166,191],"present":[29],"study,":[30],"structure-based":[32],"virtual":[33],"screening":[34],"approach":[35],"was":[36,56,75,84],"employed":[37],"to":[38,94,106],"identify":[39],"potential":[40,204],"natural":[41,49],"inhibitors":[42],"of":[43,47,61,73,145,165,179],"EphA1.":[44],"A":[45],"library":[46],"90,000":[48],"compounds":[50,100,139],"retrieved":[51],"from":[52,77],"ZINC":[54],"database":[55],"filtered":[57],"using":[58,86],"Lipinski's":[59],"rule":[60],"five,":[62],"yielding":[63],"32,901":[64],"drug-like":[65],"molecules":[66],"for":[67,209],"docking":[68,83],"analysis.":[69,117],"The":[70],"three-dimensional":[71],"structure":[72],"EphA1":[74],"obtained":[76],"AlphaFold":[79],"database,":[80],"molecular":[82],"performed":[85],"InstaDock.":[87],"Based":[88],"on":[89],"binding":[90,197],"affinity":[91,198],"scores":[92],"(-11.2":[93],"-9.4":[95],"kcal/mol),":[96],"top":[98],"320":[99],"were":[101],"shortlisted":[102],"further":[104],"subjected":[105],"PAINS":[107],"filtering,":[108],"physicochemical":[109],"evaluation,":[110],"ADMET":[111],"prediction,":[112],"carcinogenicity":[113],"assessment,":[114],"PASS":[116],"Two":[118],"compounds,":[119],"ZINC12660859":[120,194],"ZINC12661003,":[122],"demonstrated":[123],"favourable":[124],"drug-likeness,":[125],"high":[126],"gastrointestinal":[127],"absorption,":[128],"non-carcinogenicity,":[129],"predicted":[131],"antineoplastic":[132],"activity.":[133],"Interaction":[134],"analysis":[135],"revealed":[136],"that":[137],"these":[138],"bind":[140],"within":[141],"ATP-binding":[143],"pocket":[144],"domain,":[148],"forming":[149],"key":[150],"interactions":[151],"with":[152,172],"residues":[153],"such":[154],"as":[155,205],"Lys656":[156],"Asp749.":[158],"Molecular":[159],"dynamics":[160],"simulations":[161],"over":[162],"100":[163],"ns":[164],"EphA1-ZINC12660859":[167],"complex":[168],"confirmed":[169],"structural":[170],"stability,":[171,201],"stable":[173],"RMSD":[174],"(0.26":[175],"nm),":[176,182],"consistent":[177],"radius":[178],"gyration":[180],"(1.93":[181],"minimal":[183],"SASA":[184],"variation,":[185],"sustained":[187],"hydrogen":[188],"bonding":[189],"throughout":[190],"simulation.":[192],"Overall,":[193],"exhibited":[195],"strong":[196],"dynamic":[200],"suggesting":[202],"its":[203],"lead":[207],"candidate":[208],"EphA1-targeted":[210],"anticancer":[211],"therapeutics.":[212]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-27T00:00:00"}